CX11, Placebo to cx11 40 mg, CX11, Placebo to cx11 80 mg
CX11202
Phase 2 small_molecule active
Quick answer
CX11, Placebo to cx11 40 mg, CX11, Placebo to cx11 80 mg for Type 2 Diabetes Mellitus is a Phase 2 program (small_molecule) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lacuna Pharma Pty Ltd
- Indication
- Type 2 Diabetes Mellitus
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active